Jeff Yass’s Olema Oncology, Inc. Common Stock OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Sell
182,300
-189,900
-51% -$2.54M ﹤0.01% 6180
2026
Q1
$5.55M Sell
372,200
-31,800
-8% -$708K ﹤0.01% 4053
2025
Q4
$10.1M Buy
+404,000
New +$7.19M ﹤0.01% 3024
2024
Q4
– Sell
-16,400
Closed -$196K – 12917
2024
Q3
$196K Sell
16,400
-8,100
-33% -$104K ﹤0.01% 10493
2024
Q2
$265K Sell
24,500
-8,500
-26% -$92.2K ﹤0.01% 9737
2024
Q1
$374K Sell
33,000
-30,100
-48% -$388K ﹤0.01% 9189
2023
Q4
$885K Buy
63,100
+33,800
+115% +$454K ﹤0.01% 7287
2023
Q3
$362K Buy
29,300
+14,600
+99% +$149K ﹤0.01% 8956
2023
Q2
$133K Buy
+14,700
New +$88.8K ﹤0.01% 10696
2022
Q4
– Sell
-11,200
Closed -$31K – 13310
2022
Q3
$31K Sell
11,200
-27,000
-71% -$115K ﹤0.01% 12432
2022
Q2
$155K Sell
38,200
-32,700
-46% -$104K ﹤0.01% 10984
2022
Q1
$302K Buy
70,900
+46,400
+189% +$256K ﹤0.01% 10263
2021
Q4
$229K Buy
+24,500
New +$508K ﹤0.01% 11154

Other funds holding OLMA

Jeff Yass's OLMA Position: Q2 2026 in Review

Jeff Yass reduced its Olema Oncology, Inc. Common Stock (OLMA) stake by 56% in Q2 2026, selling an estimated $2.16M and leaving 124,952 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #7060.

Jeff Yass first reported a position in OLMA in Q4 2020 and has held it in 20 quarters since. The position peaked at $4.26M in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Jeff Yass held 124,952 shares of Olema Oncology, Inc. Common Stock worth $1.56M as of Q2 2026.
  • Jeff Yass sold 160,930 Olema Oncology, Inc. Common Stock shares in Q2 2026, an estimated $2.16M.
  • Olema Oncology, Inc. Common Stock made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7060 holding.
  • Jeff Yass first reported a position in Olema Oncology, Inc. Common Stock in Q4 2020 and has held it in 20 quarters since.
  • Jeff Yass's Olema Oncology, Inc. Common Stock position peaked at $4.26M in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Oncology, Inc. Common Stock as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.